Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Emerging
Primary summary from verified readiness
- Confidence
- 84% · stale
- Computed at
- 2026-09-22T23:27:14.984527+00:00
- Claimed
- 35
- Reported
- 35
- Verified
- 30
- Gap
- +5
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-09-22
Too early to adopt
- Why
- Two peer-reviewed primary results from independent groups (attomolar/picomolar sensitivity, 100% concordance on small cohorts) make the mechanism genuinely real, but validation is narrow (one virus, 31 samples for SLEUTH; 40 HCV samples for the companion) and therapeutic use is years out — no adoptable artifact exists today.
- Next
- Track the two May-2026 Nature Biotechnology papers and watch for independent replication, a multi-pathogen panel, and any in-cell/in-vivo therapeutic demonstration before treating as a usable platform
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 7
- Tier 2
- 0
- Tier 3
- 0
- Supports
- 5
- Contradicts
- 2
- Context
- 0
- Latest observed
- 2026-05-18
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Revision 2
- 2026-07-19 Reading moved from emerging to emerging.
- 2026-09-22 Reading moved from emerging to emerging.